1.035USD-0.96%Mkt Cap: 199.34M USDP/E: —Last update: 2026-06-01
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. It focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophage…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap199.34M USD
Enterprise Value204.06M USD
Revenue (TTM)5.13M USD
Gross Profit-1.96M USD
Net Income (TTM)-58.01M USD
Revenue/Share0.0430 USD
Last Price1.035 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees82
CountryUS
SectorHealthcare
IndustryMedical Devices
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.89
PEG—
EV/EBITDA-4.22
EV/Revenue39.75
P/S38.27
P/B-27.84
EPS (TTM)-0.34
EPS (Forward)-0.17
52W Range
0.900019% of range1.629
52W High1.629 USD
52W Low0.9000 USD
Profitability
Gross Margin-41.73%
Oper. Margin-964.49%
EBITDA Margin0.00%
Profit Margin-1232.68%
ROE-530.45%
ROA-143.43%
Growth
Revenue Growth51.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF-46.48M USD
CapEx (TTM)197.00K USD
FCF Margin-497.13%
FCF Yield-12.80%
Net Debt-2.57M USD
Net Debt/EBITDA0.05
Balance Sheet
Debt/Equity2.36
Current Ratio1.07
Quick Ratio1.02
Book Value/Sh-0.0370 USD
Cash/Share0.1540 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)3.900 USD
Target Range2.000 USD – 9.000 USD
# Analysts5
Ownership
Shares Out.190.76M
Float140.58M
Insiders26.53%
Institutions19.37%
Short Interest
Short Ratio7.0d
Short % Float4.30%
Short % Out.3.47%
Shares Short6.62M
Short (prev mo.)6.23M
Technical
SMA 501.130 (-8.4%)
SMA 2001.162 (-10.9%)
Beta1.10
S&P 52W Chg27.94%
Avg Vol (30d)912.00K
Avg Vol (10d)1.20M
Technical Indicators
RSI (14)46.6
MACD-0.0250
MACD Signal-0.0385
MACD Hist.+0.0135
BB Upper1.126 USD
BB Middle1.038 USD
BB Lower0.9493 USD
BB Width17.07%
ATR (14)0.0657 USD
Vol Ratio (20d)0.49x